LRRK2 and Parkinson disease: Inhibition of NCLX in midbrain neurons in LRRK2 mutation is specifically important because it enhances the mitochondrial calcium level that increase probability to open permeability transition pore in mitochondria and trigger cell death in response to additional stresses which are typical for PD pathology such as oligomeric α-synuclein and dopamine48,49.